Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum 2024
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
wang luyao
In Vitro Services Provider Finds Fertile Ground on Hong Kong’s Bourse
New Funding Values Chinese Artificial-Heart Maker at 1 Billion Yuan
Could U.S. Targeting of Two China Genomics Firms be Related to Huawei?
Baidu Attempts Medical Content Comeback After Search Result Scandals
In Depth: Why China’s Drug-Review Revamp Is Stalling
rare disease drug expert He Euyi and biological medical expert
Wang
Gang. But budget constraints
Chinese Genomics Giant BGI Wages Patent War Against Illumina
Chinese DNA Sequencing Firm BGI Faces Legal Battle with Illumina
Latest Chinese Tariffs Unlikely to Hit Health Care Hard, Analysts Say
Genome Sequencing Giant BGI's Fundraising Flops
BGI’s Gene-Sequencing Unit Raises Only Fifth of Expected Amount Amid Market Concerns Over Its Sales, Sources Say
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通